Clik here to view.
SanBio Announces Publication of STEMTRA Phase 2 Interim Analysis for SB623 in...
TOKYO & MOUNTAIN VIEW, Calif. The SanBio Group (SanBio Co., Ltd. and its subsidiary SanBio, Inc.) (TSE:4592) a scientific leader in regenerative medicine for neurological disorders, today...
View ArticleClik here to view.
Veristat Launches Business Operations in Spain and Names Dr. Montserrat...
SOUTHBOROUGH, Mass. Veristat, a scientific-minded global clinical research organization (CRO), announced today the launch of business operations in Spain and the appointment of Montserrat (Montse)...
View ArticleClik here to view.
Veristat Supported Marketing Applications for 10% of All FDA Novel Drug...
SOUTHBOROUGH, Mass. Veristat, a scientific-minded global clinical research organization (CRO), announced today that they supported the marketing applications for 10% of the 2020 US Food and Drug...
View ArticleClik here to view.
Avacta announces AffyXell $7.3 Million Series A Financing
CAMBRIDGE, England & SEOUL, South Korea Avacta Group plc (AIM: AVCT), the developer of Affimer® biotherapeutics and reagents, is pleased to announce that AffyXell Therapeutics (“AffyXell”), the...
View ArticleClik here to view.
サンゴバン・ライフサイエンシズがT細胞増殖用の高効率細胞培養用バッグを発表
米メリーランド州ゲイザースバーグ （ビジネスワイヤ） — 細胞・遺伝子治療薬製造のための材料科学ベースソリューションで業界をリードするサンゴバン・ライフサイエンシズは本日、T細胞由来の治療薬向けに特別設計した新しい細胞培養用バッグを発表しました。...
View ArticleClik here to view.
圣戈班生命科学推出用于T细胞扩增的高效细胞培养袋
马里兰州盖瑟斯堡 (美国商业资讯)–基于材料科学的细胞和基因疗法生产解决方案的行业领导者圣戈班生命科学(Saint-Gobain Life Sciences)今天推出专门为T细胞衍生疗法设计的新款细胞培养袋。 本新闻稿包含多媒体。此处查看新闻稿全文： https://www.businesswire.com/news/home/20210226005356/zh-CN/...
View ArticleClik here to view.
Pharmaron Acquires State-of-the-Art Biomanufacturing Site in the United...
BEIJING Pharmaron Beijing Co., Limited (Stock Code: 300759.SZ/3759.HK) (“Pharmaron”) announced today that it has entered into a definitive agreement to acquire Allergan Biologics Limited (“The ABL...
View ArticleClik here to view.
Cell Therapy for Cartilage Regeneration Gets a Boost With Hyaluronic Acid...
TOKYO Regenerative therapy to treat knee joint damages gets a boost with a breakthrough technology of growing ideal type of cartilage cells including chondroprogenitors and mesenchymal stem cells...
View ArticleClik here to view.
Veristat Congratulates Origin Biosciences for FDA Approval of Nulibry During...
SOUTHBOROUGH, Mass. Veristat, a scientific-minded, global clinical research organization (CRO), today congratulated Origin Biosciences for their FDA approval of Nulibry (fosdenopterin) for injection...
View ArticleClik here to view.
软骨再生细胞疗法在3D组织工程平台中通过富含透明质酸的软骨细胞得到增强
东京 (美国商业资讯)–据江户川医院院长(Edogawa Hospital) Shojiro Katoh博士在《膝盖》(The...
View ArticleClik here to view.
ヒアルロン酸が豊富な軟骨細胞培養に3次元組織工学プラットフォームで成功―軟骨再生治療の新たな一歩
東京 （ビジネスワイヤ） — 「 ヒアルロン酸が豊富な軟骨前駆細胞や間葉系幹細胞を含む軟骨細胞を培養するという新しい技術により、膝関節損傷の細胞治療が新たな段階を迎えた」という江戸川病院院長の加藤正二郎医師らによる論文がThe KNEE誌（ https://doi.org/10.1016/j.knee.2021.02.019）に掲載されました。Edogawa Evolutionary...
View ArticleClik here to view.
Genetron Health to Present at Science/AAAS Webinar About Early Cancer...
BEIJING Genetron Holdings Limited (“Genetron Health” or the “Company”, NASDAQ: GTH), a leading precision oncology company in China that specializes in offering molecular profiling tests, early...
View ArticleClik here to view.
Celltrion Healthcare receives positive CHMP opinion for subcutaneous...
INCHEON, South Korea Celltrion Healthcare today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended Remsima® SC for direct...
View ArticleClik here to view.
Athersys Reports That Healios Has Completed Enrollment in the ONE-BRIDGE...
CLEVELAND Athersys, Inc. (Nasdaq: ATHX) announced today that its partner HEALIOS K.K. (Healios) has completed enrollment in the ONE-BRIDGE study in Japan evaluating MultiStem® (invimestrocel) in...
View ArticleClik here to view.
Organicell Announces Positive Results of Initial COVID-19 Zofin™ Patient...
MIAMI Organicell Regenerative Medicine, Inc. (OTCMKTS: BPSR), a clinical-stage biopharmaceutical company dedicated to the development of regenerative therapies, today announced positive results for...
View ArticleClik here to view.
Wipro Partners with Transcell Oncologics to Transform Vaccine Safety Assessment
NEW YORK & BANGALORE, India Wipro Limited (NYSE: WIT, BSE: 507685, NSE: WIPRO), a leading global information technology, consulting and business process services company, today announced a...
View ArticleClik here to view.
Veristat Appoints Colleen Pelton Chief Talent Officer
SOUTHBOROUGH, Mass. Veristat, a scientific-minded global clinical research organization (CRO), announced the appointment of Colleen Pelton to the role of Chief Talent Officer. Ms. Pelton joins...
View ArticleClik here to view.
Shoreline Biosciences and BeiGene Announce Strategic Worldwide Collaboration...
SAN DIEGO & CAMBRIDGE, Mass. & BEIJING Shoreline Biosciences, Inc., a biotechnology company developing intelligently designed allogeneic off-the-shelf, standardized and targeted natural...
View ArticleClik here to view.
Heartseed Raises $37 Million in Series C Funding to Accelerate Development of...
TOKYO Heartseed, a Tokyo-based biotechnology company developing iPSC-derived cardiomyocytes for heart failure (HF), today announced it has raised 4 Billion-yen (approx. $37 Million) at Series C...
View ArticleClik here to view.
Reversal of Aging of Human Cartilage, Restoring Youthfulness; the First of...
TOKYO Cartilage of the knee joint, when severely damaged by age related wear and tear or injury or osteoarthritis, which is removed and usually discarded, during joint replacement surgery, now could...
View Article